ask="41.79"
ask_size="300"
average_daily_volume="1847670"
bid="40.78"
bid_size="300"
book_value="11.83"
change="+2.65"
change_from_200_day_moving_average="-14.84"
change_from_50_day_moving_average="-1.70"
change_from_52_week_high="-56.71"
change_From_52_week_low="9.91"
change_in_percent="+6.86%"
close="41.29"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.80"
eps_estimate_next_quarter="-1.33"
eps_estimate_next_year="-5.05"
ex_dividend_date="N/A"
float_shares="70883000"
high="41.75"
high_52_weeks="98.00"
last_trade_date="1/4/2017"
last_trade_price="41.29"
last_trade_size="117886"
last_trade_time="4:00pm"
low="38.34"
low_52_weeks="31.38"
market_capitalization="3.54B"
moving_average_200_day="56.13"
moving_average_50_day="42.99"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="61.36"
open="38.59"
pe_ratio="N/A"
peg_ratio="-0.17"
percent_change_from_200_day_moving_average="-26.44%"
percent_change_from_50_day_moving_average="-3.95%"
percent_change_from_52_week_high="-57.87%"
percent_change_from_52_week_low="+31.58%"
previous_close="38.64"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.27"
price_per_sales="89.00"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="5.52"
stock_exchange="NMS"
symbol="ALNY"
volume="1089360"
weeks_range_52="31.38 - 98.00"
